
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
Guangyu Ding, Jiaqiang Ma, Jing‐Ping Yun, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 608-618
Closed Access | Times Cited: 138
Guangyu Ding, Jiaqiang Ma, Jing‐Ping Yun, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 608-618
Closed Access | Times Cited: 138
Showing 1-25 of 138 citing articles:
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 308
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 308
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 89
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 89
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
A blueprint for tumor-infiltrating B cells across human cancers
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, et al.
Science (2024) Vol. 384, Iss. 6695
Closed Access | Times Cited: 56
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, et al.
Science (2024) Vol. 384, Iss. 6695
Closed Access | Times Cited: 56
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2175-2185
Open Access | Times Cited: 51
Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2175-2185
Open Access | Times Cited: 51
Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
Chong Zhang, Xiangyu Wang, Jie‐Liang Zuo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006425-e006425
Open Access | Times Cited: 44
Chong Zhang, Xiangyu Wang, Jie‐Liang Zuo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006425-e006425
Open Access | Times Cited: 44
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Tertiary lymphoid structures in anticancer immunity
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 629-646
Closed Access | Times Cited: 20
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 629-646
Closed Access | Times Cited: 20
Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics
Gang Che, Jie Yin, Wankun Wang, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101080-101080
Closed Access | Times Cited: 16
Gang Che, Jie Yin, Wankun Wang, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101080-101080
Closed Access | Times Cited: 16
Tertiary lymphoid structures in cancer: maturation and induction
Yulu Chen, Yuhao Wu, Guorong Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Yulu Chen, Yuhao Wu, Guorong Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis
Yifan Zhang, Guangjian Liu, Qianwen Zeng, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1370-1385.e9
Open Access | Times Cited: 16
Yifan Zhang, Guangjian Liu, Qianwen Zeng, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1370-1385.e9
Open Access | Times Cited: 16
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010173-e010173
Open Access | Times Cited: 1
Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010173-e010173
Open Access | Times Cited: 1
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
Yihong Ling, Jian Zhong, Zelin Weng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 50
Yihong Ling, Jian Zhong, Zelin Weng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 50
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis
Xuanwen Bao, Qiong Li, Jinzhang Chen, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 811-828
Open Access | Times Cited: 48
Xuanwen Bao, Qiong Li, Jinzhang Chen, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 811-828
Open Access | Times Cited: 48
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
Role of tertiary lymphoid organs in the regulation of immune responses in the periphery
Amit I. Bery, Hailey M. Shepherd, Wenjun Li, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 43
Amit I. Bery, Hailey M. Shepherd, Wenjun Li, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 43
Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer
Qianyu Wang, Xiaofei Shen, Ran An, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Qianyu Wang, Xiaofei Shen, Ran An, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
Taiyu Shang, Tianyi Jiang, Tao Lü, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Taiyu Shang, Tianyi Jiang, Tao Lü, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response
Qianqian Zhang, Suhui Wu
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 35
Qianqian Zhang, Suhui Wu
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 35
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Wei‐Feng Qu, Meng‐Xin Tian, Hongwei Lü, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 927-941
Open Access | Times Cited: 30
Wei‐Feng Qu, Meng‐Xin Tian, Hongwei Lü, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 927-941
Open Access | Times Cited: 30
Immunobiology of cholangiocarcinoma
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 30
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 30
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
Lianyu Zhao, Song Jin, Shengyao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Lianyu Zhao, Song Jin, Shengyao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment
Kai Yan, Qingzhi Liu, Rongrong Huang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 9
Kai Yan, Qingzhi Liu, Rongrong Huang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 9